|
WO2009046338A1
|
|
Method for increasing cerebral blood flow with (+)-nilvadipine enantiomer
|
|
WO2008070875A2
|
|
Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production
|
|
KR20090059569A
|
|
Compound for inhibiting beta-amyloid production and methods of identifying the compounds
|
|
AU2007269090A1
|
|
Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof
|
|
EP1993548A2
|
|
Compounds for inhibiting beta-amyloid production
|
|
KR20080095836A
|
|
Modulation of angiogenesis by a-beta peptide fragments
|
|
CA2603676A1
|
|
Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
|
|
CN1809352A
|
|
Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
|
|
AU2004212965A1
|
|
Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors
|
|
AU2003285153A1
|
|
Organic anion transport polypeptide related protein-4 (OATPRP4) gene in tourette syndrome and related disorders
|
|
US7052852B1
|
|
CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease
|
|
CA2467922A1
|
|
Modulation of angiogenesis by a-beta peptides
|
